Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • PYC gets FDA clearance to kick off human trials for its investigative drug combatting blindness
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • PYC gets FDA clearance to kick off human trials for its investigative drug combatting blindness
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • PYC gets FDA clearance to kick off human trials for its investigative drug combatting blindness
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • PYC gets FDA clearance to kick off human trials for its investigative drug combatting blindness
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • PYC gets FDA clearance to kick off human trials for its investigative drug combatting blindness
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • PYC Therapeutics receives Orphan Drug Designation for ADOA treatment
    PYC Therapeutics receives Orphan Drug Designation for ADOA treatment
    • News

  • All eyes on PYC as it doses first patient for eye disease trial
    All eyes on PYC as it doses first patient for eye disease trial
    • News

  • PYC gets FDA clearance to kick off human trials for its investigative drug combatting blindness
    PYC gets FDA clearance to kick off human trials for its investigative drug combatting blindness
    • News

  • Newly rebranded xReality Group’s military VR business division progresses
    • News

    Newly rebranded xReality Group’s military VR business division progresses

    Having just undergone a full rebrand to match their new business direction, xReality Group (formerly ISA Group), now trading under the ticker code ASX: XRG, are making headway in their Defence focused business division. The refocused Company released a market update on the Operator Tactical Solutions business unit which creates virtual reality products for training

    Read More
    Public
  • DroneShield signs new marquee customer for drone defence AI
    • News

    DroneShield signs new marquee customer for drone defence AI

    As drone technology continues to be utilised by defence departments around the world to carry out tasks previously required by a live human, counter-drone capabilities are becoming equally important with DroneShield (ASX: DRO) securing a new order from whom they expect to be a new marquee defence customer.  The order is for a variant of

    Read More
    Public
  • Viva expands fitness studio portfolio with new low cost membership brand
    • News

    Viva expands fitness studio portfolio with new low cost membership brand

    There are few things that feel as fantastic as the buzz through your body after a good Vinyaya sesh where a skilled yoga instructor has conned you into a full body workout under the guise of a ‘restorative’ yoga practice. For you non-yogis out there, I implore you to try it for yourself. It’s mildly

    Read More
    Public
  • All roads lead to HUB24 as Productivity Commission flags $6 Trillion wealth transfer
    • News

    All roads lead to HUB24 as Productivity Commission flags $6 Trillion wealth transfer

    With Australia’s aging population, the Productivity Commission on Tuesday released its first report into upcoming intergenerational wealth transfers where it forecasts $6 Trillion will be handed over in the next 30 years. While the report set tongues wagging across the public policy sector, wealth administrators HUB24 (ASX: HUB) and Class Limited (ASX: CL1) is well

    Read More
    Public
  • SenSen signs largest London casino to player tracking AI data collection
    • News

    SenSen signs largest London casino to player tracking AI data collection

    In the middle of their capital raising campaign seeking $5 million from shareholders, artificial intelligence company SenSen networks has announced its third big contract win for the week, this time a 3-year contract awarded by Hippodrome Casino in London for SenSen’s motion detection technology. The contract is SenSen’s first UK contract win for their sensor

    Read More
    Public
  • Instant PayDay lending: will wage advance apps be the next fintech craze?
    • News

    Instant PayDay lending: will wage advance apps be the next fintech craze?

    There’s a new player in the fintech lending space, with a tongue-in-cheek name that is no doubt a brazen dig at the prolific Afterpay (ASX: APT).  I’m talking about Beforepay, the platform that lets you access your wages early, for a set fee. Less: buy now, pay later. More: wage advance, buy now, with fees…not

    Read More
    Public
  • Novatti claims major fintech award, declared Best Fintech Payments Provider
    • News

    Novatti claims major fintech award, declared Best Fintech Payments Provider

    Rising digital payments company Novatti Group (ASX: NOV) is set to end what has already been a hugely productive year on a high note having on Wednesday won the Best Fintech Payments Provider award at the 6th Annual FinTech Awards. Novatti was deemed by judges to have the most innovative product that adds value to

    Read More
    Public
  • Hipages just acquired this business… Their unfortunate name comes with stacks of market potential
    • News

    Hipages just acquired this business… Their unfortunate name comes with stacks of market potential

    Despite a really unfortunate name, New Zealand online tradie marketplace “Builderscrack” has been acquired by hipages (ASX: HPG), Australia’s largest online tradie marketplace.  (I mean honestly, I can’t be the only one who thinks of a plumber’s butt peeking out of the top of jeans as he crouches under a sink when reading that website

    Read More
    Public
  • Coles to sell drinking kava following declassification as a prohibited substance
    • News

    Coles to sell drinking kava following declassification as a prohibited substance

    Following on from the Federal Government’s decision to declassify drinking kava as a prohibited substance last month, Fiji Kava (ASX: FIJ) has seen strong demand from their online pre-order with such demand even promoting Coles to place its first orders for the native drink of Fiji.  Interest around drinking kava comes after Trade Minister DanRead More
    Public
  • From bed linen to defense- material tech company Alexium enters new market
    • News

    From bed linen to defense- material tech company Alexium enters new market

    Materials tech has come a long way. Think kevlar, lycra and foam- all complex textile materials that are integrated into everyday items.  The dynamic field of textile science encompasses fibers, dyes and production methods. The next generation of textile product innovation lies in phase change textiles. These contain materials that react immediately with changes in

    Read More
    Public
  • «
  • ‹
  • 206
  • 207
  • 208
  • 209
  • 210
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.